Initiation of Autoimmune Diabetes by Developmentally Regulated Presentation of Islet Cell Antigens in the Pancreatic Lymph Nodes

Little is known about the events triggering lymphocyte invasion of the pancreatic islets in prelude to autoimmune diabetes. For example, where islet-reactive T cells first encounter antigen has not been identified. We addressed this issue using BDC2.5 T cell receptor transgenic mice, which express a receptor recognizing a natural islet beta cell antigen. In BDC2.5 animals, activated T cells were found only in the islets and the lymph nodes draining them, and there was a close temporal correlation between lymph node T cell activation and islet infiltration. When naive BDC2.5 T cells were transferred into nontransgenic recipients, proliferating cells were observed only in pancreatic lymph nodes, and this occurred significantly before insulitis was detectable. Surprisingly, proliferation was not seen in 10-day-old recipients. This age-dependent dichotomy was reproduced in a second transfer system based on an unrelated antigen artificially expressed on beta cells. We conclude that beta cell antigens are transported specifically to pancreatic lymph nodes, where they trigger reactive T cells to invade the islets. Systemic or extrapancreatic T cell priming, indicative of activation via molecular mimicry or superantigens, was not seen. Compromised presentation of beta cell antigens in the pancreatic lymph nodes of juvenile animals may be the root of a first “checkpoint” in diabetes progression.

[1]  C. Kurts,et al.  Brief Definitive Report Major Histocompatibility Complex Class I–restricted Cross-presentation Is Biased towards High Dose Antigens and Those Released during Cellular Destruction , 2022 .

[2]  C. Kurts,et al.  Cross-tolerance: A Pathway for Inducing Tolerance to Peripheral Tissue Antigens , 1998, The Journal of experimental medicine.

[3]  G. Hedlund,et al.  Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. , 1998, Journal of immunology.

[4]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[5]  C. Benoist,et al.  Cytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes , 1998, The Journal of experimental medicine.

[6]  A. Jevnikar,et al.  Protective and destructive effects of microbial infection in insulin-dependent diabetes mellitus. , 1998, Seminars in immunology.

[7]  M. V. von Herrath,et al.  Role of viruses in type I diabetes. , 1998, Seminars in immunology.

[8]  J. Buer,et al.  Changes in function of antigen‐specific lymphocytes correlating with progression towards diabetes in a transgenic model , 1998, The EMBO journal.

[9]  M. Mattéi,et al.  Genetic control of diabetes progression. , 1997, Immunity.

[10]  R. Tisch,et al.  CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. , 1997, Journal of immunology.

[11]  H. Mcdevitt,et al.  Involvement of β7 Integrin and Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1) in the Development of Diabetes in Nonobese Diabetic Mice , 1997, Diabetes.

[12]  D. Mathis,et al.  The NOD mouse. , 1997, Research in immunology.

[13]  J. Parker,et al.  CD4+ and CD8+ T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse. , 1997, Research in immunology.

[14]  C. Janeway,et al.  The role of CD4 and CD8 T cells in type I diabetes in the NOD mouse. , 1997, Research in immunology.

[15]  E. Leiter,et al.  Initiation of autoimmune diabetes in NOD/Lt mice is MHC class I-dependent. , 1997, Journal of immunology.

[16]  H. Mcdevitt,et al.  Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice. , 1997, Diabetes.

[17]  H. von Boehmer,et al.  Cell division in the compartment of naive and memory T lymphocytes , 1996, European journal of immunology.

[18]  I. Lieberam,et al.  Peripheral tolerance of CD4 T cells following local activation in adolescent mice , 1996, European journal of immunology.

[19]  D. Wegmann The immune response to islets in experimental diabetes and insulin-dependent diabetes mellitus. , 1996, Current opinion in immunology.

[20]  J. Miller,et al.  Constitutive class I-restricted exogenous presentation of self antigens in vivo , 1996, The Journal of experimental medicine.

[21]  B. Roep T-Cell Responses to Autoantigens in IDDM: The Search for the Holy Grail , 1996, Diabetes.

[22]  C. Benoist,et al.  The role of CD8+ T cells in the initiation of insulin‐dependent diabetes mellitus , 1996, European journal of immunology.

[23]  H. Mcdevitt,et al.  CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. , 1996, Journal of immunology.

[24]  R. Tisch,et al.  Insulin-Dependent Diabetes Mellitus , 1996, Cell.

[25]  L. Picker,et al.  Lymphocyte Homing and Homeostasis , 1996, Science.

[26]  C. Benoist,et al.  Checkpoints in the progression of autoimmune disease: lessons from diabetes models. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Janeway,et al.  CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells , 1996, The Journal of experimental medicine.

[28]  G. Nepom Glutamic acid decarboxylase and other autoantigens in IDDM. , 1995, Current opinion in immunology.

[29]  C Benoist,et al.  T helper cell subsets in insulin-dependent diabetes. , 1995, Science.

[30]  C. Boitard,et al.  Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model , 1995, The Journal of experimental medicine.

[31]  T. Sumida,et al.  Prevention of insulitis and diabetes in Β2-microglobulin-deficjent non-obese diabetic mice , 1994 .

[32]  R. Tisch,et al.  Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process , 1994, The Journal of experimental medicine.

[33]  R. Leslie,et al.  Early Environmental Events as a Cause of IDDM: Evidence and Implications , 1994, Diabetes.

[34]  H. Drexhage,et al.  Immunohistochemical Characterization of Monocytes-Macrophages and Dendritic Cells Involved in the Initiation of the Insulitis and β-Cell Destruction in NOD Mice , 1994, Diabetes.

[35]  H. Mcdevitt,et al.  A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. , 1994, Immunity.

[36]  R. Jaenisch,et al.  β2-Microglobulin–Deficient NOD Mice Do Not Develop Insulitis or Diabetes , 1994, Diabetes.

[37]  E. Leiter,et al.  Major Histocompatibility Complex Class I-Deficient NOD-B2mnull Mice are Diabetes and Insulitis Resistant , 1994, Diabetes.

[38]  B. Bergman,et al.  Islet-Specific T-Cell Clones From the NOD Mouse Respond to β-Granule Antigen , 1994, Diabetes.

[39]  B. Bergman,et al.  Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. , 1994, Diabetes.

[40]  C. Benoist,et al.  Major histocompatibility complex class I molecules are required for the development of insulitis in non‐obese diabetic mice , 1993, European journal of immunology.

[41]  C. Benoist,et al.  Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.

[42]  H. Mcdevitt,et al.  Antigen‐presenting cells in adoptively transferred and spontaneous autoimmune diabetes , 1993, European journal of immunology.

[43]  Y. Mullen,et al.  Marked dendritic cell-T cell cluster formation in the pancreatic lymph node of the non-obese diabetic mouse. , 1992, Immunology.

[44]  S. Rastan,et al.  Lymphoid development in mice congenitally lacking T cell receptor alpha beta-expressing cells. , 1992, Science.

[45]  Susumu Tonegawa,et al.  RAG-1-deficient mice have no mature B and T lymphocytes , 1992, Cell.

[46]  H. Pircher,et al.  Preferential positive selection of Vα2+CD8+ T cells in mouse strains expressing both H‐2k and T cell receptor Vαa haplotypes: determination with a Vα2‐specific monoclonal antibody , 1992, European journal of immunology.

[47]  D. Gray,et al.  Mice lacking MHC class II molecules , 1991, Cell.

[48]  K. Haskins,et al.  Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. , 1990, Science.

[49]  Bart O. Roep,et al.  T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins , 1990, Nature.

[50]  K. Lafferty,et al.  T-Lymphocyte Clone Specific for Pancreatic Islet Antigen , 1988, Diabetes.

[51]  D. Monos,et al.  Insulin dependent diabetes mellitus as an autoimmune disease. , 1988, In vivo.

[52]  D. Hanahan,et al.  Non-tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic β cells , 1987, Nature.

[53]  A. Czitrom,et al.  Ontogeny of priming of cytotoxic T cells to minor alloantigens: the development of direct priming precedes that of cross‐priming , 1986, European journal of immunology.

[54]  J. Lowenthal,et al.  Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells , 1985, Nature.

[55]  I. Weissman,et al.  A cell-surface molecule involved in organ-specific homing of lymphocytes , 1983, Nature.

[56]  J. Sprent,et al.  A monoclonal antibody discriminating between subsets of T and B cells. , 1981, Journal of immunology.

[57]  E. Unanue,et al.  A defect in the antigen-presenting function of macrophages from neonatal mice , 1979, Nature.